StonvexLoading…
StonvexStonvexStonvexCore line items from ENTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $35.77M | $18.61M | $65.32M | $50.20M |
Operating Income | $-23.11M | $-11.25M | $-85.35M | $-66.96M |
Net Income | $-25.03M | $-11.94M | $-81.89M | $-63.19M |
EPS (Diluted) | $-0.87 | $-0.42 | $-3.84 | $-2.96 |
Total Assets | $314.70M | $329.50M | $280.73M | $301.03M |
Total Liabilities | $198.12M | $202.91M | $216.01M | $221.75M |
Cash & Equivalents | $34.93M | $37.44M | $32.30M | $44.81M |
Free Cash Flow OCF − CapEx | $-19.01M | $-11.84M | $-32.17M | $-24.22M |
Shares Outstanding | 29.06M | 29.02M | 21.39M | 21.38M |